Abstract
The investigation on antibiotic stewardship in neonatal intensive care unit in China is scarce. This study aimed to analyze the effect of a comprehensive 2-year antibiotic stewardship in a level 4 NICU. During this baseline period from October 1st 2017 to October 1st 2019, continuation of empirical antibiotic therapy for ruled-out sepsis courses was beyond 72 h and for pneumonia was more than 7 days. Meropenem or vancomycin was used even if they were not the only bacterial sensitive antibiotics. The intervention period was from October 2nd 2019 to August 23rd 2021. Three areas for quality improvement were targeted in our center: discontinuation of antibiotic use in ruled-out sepsis within 72 h, treatment duration for culture-negative pneumonia less than 7 days, and vancomycin or meropenem was not used unless the cultured bacteria was only susceptible to them. The total antibiotic consumption decreased from 791.1 to 466.3 days of therapy per 1000 patient days from baseline to intervention period. Antibiotics were stopped within 72 h for 47.48% patients with rule-out sepsis and within 7 days for 75.70% patients with pneumonia compared with 11.56% and 37.69% during the baseline period respectively. The prevalence of multi-drug resistance bacteria decreased from 67.20 to 48.90%. The total use rate of meropenem or vancomycin decreased from 7.6 to 1.8%. Our quality improvement approach on antibiotic strategy significantly reduced antibiotic use and prevalence of multi-drug resistance bacteria in our NICU.
Similar content being viewed by others
Availability of data and material
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Alliance for Maternal and Newborn Health Improvement (AMANHI) mortality study group (2018) Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study. Lancet Glob Health 6(12):e1297–e1308
Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team (2005) 4 million neonatal deaths: when? Where? Why? Lancet (London, England) 365(9462):891–900
Jiang S, Yang C, Yang C, Yan W, Shah V, Shah PS, Lee SK, Yang Y, Cao Y, REIN-EPIQ Study Group (2020) Epidemiology and microbiology of late-onset sepsis among preterm infants in China, 2015–2018: A cohort study. Int J Infect Dis 96:1–9
Zemlin M, Stutz R (2020) Real-life clinical studies are needed after a quality improvement study in neonatal sepsis showed unexpected improvements. Acta Paediatr (Oslo, Norway: 1992) 109(6):1084–1085
Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan AF, Yoder BA, Eichenwald EC, DeMauro SB (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med 200(6):751–759
Ting JY, Paquette V, Ng K, Lisonkova S, Hait V, Shivanada S, Tilley P, Osiovich H, Roberts A (2019) Reduction of inappropriate antimicrobial prescriptions in a tertiary neonatal intensive care unit after antimicrobial stewardship care bundle implementation. Pediatr Infect Dis J 38(1):54–59
Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, Ambalavanan N, Benjamin DK Jr, NICHD Neonatal Research Network (2009) Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123(1):58–66
Liu J, Fang Z, Yu Y, Ding Y, Liu Z, Zhang C, He H, Geng H, Chen W, Zhao G, Liu Q, Wang B, Sun X, Wang S, Sun R, Fu D, Liu X, Huang L, Li J, Xing X, Deng L (2021) Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017–2019. Antimicrob Resist Infect Control 10(1):121
Rao YB, Ren ZX, Zhong JJ, Zhong XM, Cao B, Chen DM, Pan XN, Jia YP, Gao PM, Yang BY, Zhong Q, Yang J, Collaborative Study Group of Neonatal Hospital Infection Control (2018) Risk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China. J Hosp Infect 98(3):305–308
Thomson KM, Dyer C, Liu F, Sands K, Portal E, Carvalho MJ, Barrell M, Boostrom I, Dunachie S, Farzana R, Ferreira A, Frayne F, Hassan B, Jones E, Jones L, Mathias J, Milton R, Rees J, Chan GJ, Bekele D… BARNARDS Group (2021) Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS). Lancet Infect Dis 21(12): 1677–1688
Prusakov P, Goff DA, Wozniak PS, Cassim A, Scipion C, Urzúa S, Ronchi A, Zeng L, Ladipo-Ajayi O, Aviles-Otero N, Udeigwe-Okeke CR, Melamed R, Silveira RC, Auriti C, Beltrán-Arroyave C, Zamora-Flores E, Sanchez-Codez M, Donkor ES, Kekomäki S, Mainini N (2021) A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) study. EClinicalMedicine 32:100727
Sands K, Carvalho MJ, Portal E, Thomson K, Dyer C, Akpulu C, Andrews R, Ferreira A, Gillespie D, Hender T, Hood K, Mathias J, Milton R, Nieto M, Taiyari K, Chan GJ, Bekele D, Solomon S, Basu S, Chattopadhyay P, Walsh TR (2021) Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat Microbiol 6(4):512–523
Amasethu J, Kawakita T (2017) Antibiotic stewardship in perinatal and neonatal care. Semin Fetal Neonatal Med 22(5):278–283
Jiang S, Zhang L, Yan W, Li S, Han J, Zhou Q, Yang Y, Lee SK, Cao Y, REIN-EPIQ Study Group (2021) Antibiotic use in neonatal intensive care units in China: a multicenter cohort study. J Pediatr 239:136-142.e4
Subspecialty Group of Neonatology, the Society of Pediatric, Chinese Medical Association, & Professional Committee of Infectious Diseases, Neonatology Society, Chinese Medical Doctor Association (2019) Zhonghua er ke za zhi. Chin J Pediatr 57(4): 252–257
Cantey JB, Wozniak PS, Pruszynski JE, Sánchez PJ (2016) Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis 16(10):1178–1184
Ibrahim OM, Polk RE (2014) Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin N Am 28(2):195–214
Gomella TL, Cunningham MD, Eyal F (2013) Neonatology, 7th edn. McGraw-Hill Education, New York
Meyers JM, Tulloch J, Brown K, Caserta MT, D'Angio CT, & Golisano Children’s Hospital Nicu Antibiotic Stewardship Team (2020) A quality improvement initiative to optimize antibiotic use in a level 4 NICU. Pediatrics 146(5):e20193956
Flannery DD, Dysart K, Cook A, Greenspan J, Aghai ZH, Jensen EA (2018) Association between early antibiotic exposure and bronchopulmonary dysplasia or death. J Perinatol 38(9):1227–1234
Ran X, He Y, Ai Q, Shi Y (2021) Effect of antibiotic-induced intestinal dysbacteriosis on bronchopulmonary dysplasia and related mechanisms. J Transl Med 19(1):155
Bekhof J, Reitsma JB, Kok JH, Van Straaten IH (2013) Clinical signs to identify late-onset sepsis in preterm infants. Eur J Pediatr 172(4):501–508
Weintraub AS, Cadet CT, Perez R, DeLorenzo E, Holzman IR, Stroustrup A (2013) Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology 103(3):235–240
Sands K, Carvalho MJ, Portal E, Thomson K, Dyer C, Akpulu C, Andrews R, Ferreira A, Gillespie D, Hender T, Hood K, Mathias J, Milton R, Nieto M, Taiyari K, Chan GJ, Bekele D, Solomon S, Basu S, Chattopadhyay P, Walsh TR (2021) Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat Microbiol 6(4):512–523
Pokhrel B, Koirala T, Shah G, Joshi S, Baral P (2018) Bacteriological profile and antibiotic susceptibility of neonatal sepsis in neonatal intensive care unit of a tertiary hospital in Nepal. BMC Pediatr 18(1):208
Vivas R, Barbosa A, Dolabela SS, Jain S (2019) Multidrug-resistant bacteria and alternative methods to control them: an overview. Microbial Drug Resist (Larchmont, N.Y.) 25(6):890–908
Reboredo D, Emonet S (2020) Rapid microbiology and antimicrobial stewardship to combat antibiotic resistance. Rev Med Suisse 16(710):1912–1915
Fanaroff AA, Fanaroff JM (2020) Advances in neonatal infections. Am J Perinatol 37(S O2):S5–S9
Gkentzi D, Dimitriou G (2019) Antimicrobial stewardship in the neonatal intensive care unit: an update. Curr Pediatr Rev 15(1):47–52
Gardete S, Tomasz A (2014) Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Investig 124(7):2836–2840
WHO (2013) Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources, 2nd edn. World Health Organization, Geneva
Funding
This study is funded by National Key R&D Program of China (NO.2021YFC2701700), Guangzhou Science Project (202102080104). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Author information
Authors and Affiliations
Contributions
XF, YS, and ZX performed the trials, YH, WJ and HJ, ZQ, YH, WC, and PJ collected and analyzed data and collected the references, RZ was a major contributor in writing the manuscript, and YJ and NC designed this study and edited the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
Applicable.
Name of the ethics committee that approved the study
Guangdong Women and Children Hospital Ethics committee, Number 202201127.
Consent to participate
Obtained.
Consent for publication
Obtained.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ren, Z., Yang, S., Han, J. et al. Reduction of antibiotic use and multi-drug resistance bacteria infection in neonates after improvement of antibiotics use strategy in a level 4 neonatal intensive care unit in southern China. Eur J Clin Microbiol Infect Dis 42, 87–98 (2023). https://doi.org/10.1007/s10096-022-04522-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-022-04522-4